| Literature DB >> 27122708 |
Shusuke Yagi1, Masashi Akaike2, Ken-Ichi Aihara3, Daiju Fukuda4, Masayoshi Ishida1, Takayuki Ise1, Toshiyuki Niki1, Yuka Sumitomo-Ueda1, Koji Yamaguchi1, Takashi Iwase1, Yoshio Taketani1, Hirotsugu Yamada1, Takeshi Soeki1, Tetsuzo Wakatsuki1, Michio Shimabukuro4, Masataka Sata1.
Abstract
UNLABELLED: It is well-known that aldosterone plays an important role in reabsorption of sodium and fluid, and in potassium excretion in kidneys via epithelial mineralocorticoid receptor (MR) activation. Recent studies have shown that aldosterone causes cardiovascular remodeling not only in a blood pressure-dependent manner, but also in a blood pressure-independent manner by decreasing nitric oxide bioavailability and modulating oxidative stress, leading to vascular inflammation. In addition, MR blockade does provide beneficial effects associated with cardiovascular protection, resulting in a reduction of cardiovascular morbidity and mortality. A growing body of evidence suggests that MR blockade is a promising therapeutic target to help prevent cardiovascular events. KEY WORDS: Aldosterone; Mineralocorticoid receptor; Nitrix oxide; Renin-angiotensin-aldosterone system.Entities:
Year: 2013 PMID: 27122708 PMCID: PMC4804831
Source DB: PubMed Journal: Acta Cardiol Sin ISSN: 1011-6842 Impact factor: 2.672